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Abstract
Background: Given the restricted distribution of Schistosoma mekongi in one province in Lao People’s Democratic
Republic (Lao PDR) and two provinces in Cambodia, together with progress of the national control programmes
aimed at reducing morbidity and infection prevalence, the elimination of schistosomiasis mekongi seems feasible.
However, sensitive diagnostic tools will be required to determine whether elimination has been achieved. We
compared several standard and novel diagnostic tools in S. mekongi-endemic areas.
Methods: The prevalence and infection intensity of S. mekongi were evaluated in 377 study participants from four
villages in the endemic areas in Lao PDR and Cambodia using Kato-Katz stool examination, antibody detection
based on an enzyme-linked immunosorbent assay (ELISA) and schistosome circulating antigen detection by
lateral-flow tests. Two highly sensitive test systems for the detection of cathodic and anodic circulating antigens
(CCA, CAA) in urine and serum were utilized.
Results: Stool microscopy revealed an overall prevalence of S. mekongi of 6.4% (one case in Cambodia and 23
cases in Lao PDR), while that of Opisthorchis viverrini, hookworm, Trichuris trichiura, Ascaris lumbricoides and Taenia
spp. were 50.4%, 28.1%, 3.5%, 0.3% and 1.9%, respectively. In the urine samples, the tests for CCA and CAA detected
S. mekongi infections in 21.0% and 38.7% of the study participants, respectively. In the serum samples, the CAA
assay revealed a prevalence of 32.4%, while a combination of the CAA assay in serum and in urine revealed a
prevalence of 43.2%. There was a difference between the two study locations with a higher prevalence reached in
the samples from Lao PDR.
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Conclusions: The CCA, CAA and ELISA results showed substantially higher prevalence estimates for S. mekongi
compared to Kato-Katz thick smears. Active schistosomiasis mekongi in Lao PDR and Cambodia might thus have
been considerably underestimated previously. Hence, sustained control efforts are still needed to break transmission
of S. mekongi. The pivotal role of highly sensitive diagnostic assays in areas targeting elimination cannot be
overemphasised.
Keywords: Cambodia, Food-borne trematodes, Kato-Katz, Lao People’s Democratic Republic, Point-of-care
circulating cathodic antigen, Schistosoma mekongi, Serology, Soil-transmitted helminths, Up-converting phosphor-
lateral-flow circulating anodic antigen
Multilingual abstracts
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guages of the United Nations.
Background
Human schistosomiasis is caused by any of six species
of blood flukes, namely Schistosoma mansoni, S. japoni-
cum, S. haematobium, S. mekongi, S. intercalatum and
S. guineensis [1]. The latter three species are not only in
a clear minority but are also geographically restricted.
S. intercalatum is endemic along part of Congo River
and S. guineensis is found in lower Guinea on the
African continent, while S. mekongi exists in limited
areas near the border between Lao People’s Democratic
Republic (Lao PDR) and Cambodia. Transmission of
S. mekongi is highly focal [2, 3] with the overall distribu-
tion delineated by environmental variables suitable for
the intermediate host snail Neotricula aperta [4]. The
at-risk population is estimated at around 50,000 house-
holds comprising an estimated 150,000 people [2]
(Fig. 1). Infection and re-infection in the endemic areas
sustain the severe, chronic consequences of schistosome
infection with its various complications [5]. Due to their
high level of water contact, children are at the highest
risk, which might result in retardation of growth and
cognitive development.
The World Health Organization (WHO) roadmap
for elimination of neglected tropical diseases (NTDs)
[6] and the Regional Action Plan for NTDs in the
Western Pacific Region for 2012–2016 issued by
WHO’s Western Pacific Region Office (WPRO) [7]
recommend targeting schistosomiasis mekongi for
elimination. Delineation of infection occurrence based
on valid documentation is a necessary step to reach
this goal and success depends crucially on the avail-
ability of highly sensitive diagnostic techniques pro-
viding non-equivocal prevalence values in remaining
endemic pockets. In mass deworming campaigns,
schistosomiasis is treated with oral single-dose prazi-
quantel (40 mg/kg body weight) since the early 1980s
when this drug was introduced [8]. The current approach
in communities affected by S. mekongi consists of prevent-
ive chemotherapy targeting at-risk populations (e.g. the
entire population of villages along the Mekong) without
prior diagnosis, complemented with the distribution of in-
formation, education and communication (IEC) packages
and improvement of water, sanitation and hygiene
(WASH) whenever resources allow [9]. The next stage
now being considered is the elimination of this infection as
a public health problem. Given its restricted distribution,
eradication of S. mekongi might be envisaged. However, the
preventive chemotherapy programmes implemented in en-
demic areas in Cambodia and Lao PDR make individuals
harbouring mainly light-intensity infections likely to be
missed by the standard and widely used Kato-Katz thick
smear technique [10], resulting in imprecise assessment of
the impact of preventive chemotherapy and other interven-
tions. The solution lies in modifying the methodology ap-
plied according to the prevailing diagnostic need [11],
which obliges assays to be more sensitive and specific when
priorities shift from control of morbidity to interruption of
transmission followed by surveillance [11, 12].
Apart from egg deposition, schistosome worms excrete
(regurgitate) a number of different antigens into the
host’s blood. The circulating anodic antigen (CAA) and
its cathodic counterpart (CCA), described by Deelder
and colleagues as early as in 1976 [13], are the most
well-studied ones. Their detection in serum and urine
has been followed up with continuously improving
techniques, e.g. by de Jonge et al. [14], van Lieshout
et al. [15], van Dam et al. [16] and Corstjens et al. [17].
Importantly, detection of the antigens in either blood or
urine is evidence for an ongoing active infection as both
antigens are subject to rapid renal clearance from the
human circulation [13]. On the other hand, stool exam-
ination is marred by the problem that schistosome eggs
can be detected up to several weeks after cure [14].
Diagnostic assays should preferably be applied in the
field providing results at the point-of-care (POC) to
allow appropriate test-and-treat approaches. Diagnostics
utilizing the user-friendly, rapid-test platform based on
lateral-flow (LF) immunochromatography are well suited
for this type of test protocols [18]. As an alternative to
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egg detection in stool samples, a rapid POC assay for
CCA detection in urine (POC-CCA) was developed for
S. mansoni infection [16]. The POC-CCA assay is a visu-
ally read field assay, which takes about 20 min to
perform and which does not require any equipment ex-
cept the disposables provided with the kit. The colour
intensity of the test line on the LF strip has a correlation
to the number of eggs in the stool sample investigated
[19, 20] and the read-out is at least as sensitive as dupli-
cate Kato-Katz thick smears and considerably less labori-
ous [21–23]. Although it was specifically developed for
detection of S. mansoni infections, it has been shown to be
suitable for other intestinal schistosomiasis-causing species
such as S. mekongi and S. japonicum [24]. In order to in-
crease sensitivity and wider applicability to other schisto-
some species, another LF-based test that detects CAA
specifically and is based on the luminescent up-converting
phosphor (UCP) reporter technology has been developed
[17]. This test is referred to as UCP-LF CAA and includes
different formats, depending on the matrix and sample
volume used for testing [25]. The UCP-LF CAA test pro-
vides an assay applicable for all known Schistosoma species
(including veterinarian ones) and is assumed to allow detec-
tion down to the level of a single worm pair while main-
taining 100% specificity [25]. The CAA concentration is
considered a good proxy for the number of worms present
in the host [17]. This approach has been shown to work for
S. mansoni [26] and S. haematobium infections [27, 28] as
well as for infections by S. japonicum [29] and S. mekongi
[24]. In the People’s Republic of China, the UCP-LF CAA
assay demonstrated a S. japonicum prevalence of about 10
times higher than that estimated by triplicate Kato-Katz
thick smears [29]. However, unlike the POC-CCA, the
current UCP-LF CAA assay format is still a laboratory-
based assay due to the need of centrifugation steps, hence
not yet convenient for POC test-and-treat approaches.
Realizing that verification of transmission interruption
requires a high level of sensitivity, we aimed to evaluate
the new diagnostic techniques and to compare their
results to the standard tools (e.g. Kato-Katz). We used
Fig. 1 Lower course of the Mekong River at its crossing of the border between Lao PDR and Cambodia indicating the study area
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the UCP-LF CAA assay formats to validate the POC-
CCA test results. The POC-CCA test was expected to
have higher sensitivity than the stool examination. As an
extra control for sensitivity, Schistosoma serology based
on an enzyme-linked immunosorbent assay (ELISA) was
included as all active infections indicated by the POC-
CCA assay should test positive with this approach unless
the infection was only acquired very recently. It has to
be noted that a positive test for specific antibodies is not
only assured during active infections but indicate also
former infections as antibody titres normally persist for
a long time. This study compared a set of available as-
says to get a handle on the real prevalence and intensity
of S. mekongi infections in the endemic enclaves in
Cambodia and Lao PDR as the results should indicate a
negotiable way forward with regard to elimination of the
disease.
Methods
Study design, area and population
A cross-sectional study was conducted between February
and April 2016 in S. mekongi-endemic villages in Lao
PDR and Cambodia. Repeated stool examinations for in-
testinal helminth infections were conducted with par-
ticular emphasis on S. mekongi infection. Furthermore,
urine and serum samples were obtained from each study
participant to be tested for Schistosoma infection by the
POC-CCA, UCP-LF CAA and ELISA assays.
Four villages, two in each of the endemic districts of Lao
PDR and Cambodia, respectively, were selected. The
villages Som VenOok and Ban Yai VeunSom in Khong
district, Champasack province in southern Lao PDR were
selected together with the villages Kbal Chuor and Sre
Khoeurn in Kratié province in northern Cambodia (Fig. 1).
The main occupation of the villagers was farming and
fishing. All household members older than 6 years were
enrolled. They were invited to fill in a questionnaire
pertaining to demographic details and risk factors for
infection, information on hygiene, disease knowledge and
anthelminthic drugs taken during the last 6 months.
In Lao PDR, about 200 individuals living in Som
VenOok and Ban Yai VeunSom, situated on islands in
the Mekong River, were approached about the study.
The study households were randomly selected from a list
of households of the two villages. In Cambodia, accord-
ing to the 2008 census, the total population was 2339
people (1602 in Kbal Chuor and 737 in Sre Khoeurn).
Between 120 and 130 individuals were randomly selected
from 30 to 35 households in each village.
Sample collection and handling
Stool samples
Three stool samples were obtained from each participant
during five consecutive days. Stool samples were subjected
to examination by duplicate Kato-Katz thick smears
(41.7 mg stool per smear) examined under a light micro-
scope [30] by an experienced technician within 1 h after
preparation on site in the study villages. Prior to micros-
copy, the thick smears were allowed to clear for 30 min
after set-up. Eggs of all intestinal helminth species were
counted and recorded for each species separately. The
Kato-Katz thick smear examinations were performed
directly in a convenient place in the study village (i.e. the
village temple in Lao PDR; the village chief ’s house in
Cambodia).
Serum and urine samples
Blood samples were obtained from each participant, i.e.
5 ml venous blood (taken with vacutainers without anti-
coagulant) for serodiagnosis of S. mekongi infection and
for the UCP-LF CAA assay. Urine samples (i.e. 10 ml
urine) were obtained for CCA/CAA examination. Blood
and urine samples were stored in cool-boxes at around
4 °C. In Cambodia, blood samples were centrifuged at
Kratié Provincial Hospital a few hours after collection.
Coagulated blood samples were centrifuged at 3000 rpm
for 5 min and the upper part (serum) transferred to
fresh tubes that were frozen and kept at −20 °C immedi-
ately after spinning, while the urine samples were
directly frozen at −20 °C in the 15 ml-tubes they were
collected in [29].
All samples were transferred frozen to a central
national laboratory in Cambodia or Lao PDR and even-
tually shipped on dry ice to speciality laboratories at
Swiss Tropical and Public Health Institute (Swiss TPH)
in Basel, Switzerland and Leiden University Medical
Center (LUMC) in Leiden, The Netherlands.
Laboratory procedures
Detection of S. mekongi antibodies
Schistosoma serology was performed by ELISA at Swiss
TPH using S. mansoni adult worm extract (AWE) and
S. mansoni soluble egg antigen (SEA). Both S. mansoni
antigens show cross-reactivity with antibodies elicited by
other Schistosoma spp. (S. haematobium, S. mekongi or
S. japonicum). The combination of both serological tests
exhibits a sensitivity of 94.5% for S. mekongi infections
and a specificity of 96% and 92% for AWE and SEA,
respectively [31, 32].
AWE was prepared as described previously [31]. In
brief, adult S. mansoni worms were homogenized in
phosphate-buffered saline (PBS) of pH 7.2 containing
2-mM phenylmethylsulfonyl fluoride (PMSF). The
extract was centrifuged at 80,000 g for 3 h at 4 °C and the
pellet further extracted with PBS containing 1% Nonidet
P40. After overnight incubation at 4 °C, the suspension
was centrifuged again in the same way. After the super-
natant had been concentrated and centrifuged at 15,300 g
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for 5 min at 4 °C, it was stored in aliquots at −80 °C until
use. SEA was made from frozen S. mansoni eggs homoge-
nized in PBS of pH 7.2 on ice and subsequently extracted
for 3 h at 4 °C. The extract was centrifuged at 100,000 g
for 2 h at 4 °C and the supernatant was stored in aliquots
at −80 °C until use.
ELISA testing was carried out using Immulon 2HB
plates (Thermo Labsystems; Beverly, MA, USA) coated
with S. mansoni antigens in 0.05 M sodium carbonate
buffer (pH 9.6) for 48 h at 4 °C. After washing with tap
water containing 0.05% Tween 20, diluted sera (1:160 in
PBS, pH 7.2, 0.05% Tween 20) were added to the plates
that were incubated for 15 min at 37 °C. After additional
washing steps, horseradish peroxidase conjugated goat-
anti-human-IgG from Kirkegaard & Perry Laboratories
(KPL) (http://kem-en-tec-nordic.com/kpl/) was added.
Plates were incubated for 15 min at 37 °C, subsequently
washed and o-phenylendiamine dihydrochloride (OPD)
from Sigma (http://www.sigmaaldrich.com), diluted in 0.6-
M sodium phosphate buffer of pH 5.0 supplemented with
0.03% H2O2, was added. The reaction was stopped with 8-
M H2SO4 and the absorption read with a Thermo Scien-
tific Multiscan FC reader (http://corporate.thermofisher.-
com) at 492 nm. The results of the ELISA tests were
interpreted according to the cut-offs previously determined
by receiver operating characteristic (ROC) analysis with
sera from healthy Swiss blood donors, sera from S. mansoni
infected patients and sera from patients with other para-
sitic infections, as described before [31, 32].
Detection of circulating schistosome antigens
This part of the study was carried out at LUMC. The
POC-CCA test devices were obtained from Rapid
Medical Diagnostics (Pretoria, South Africa) and tests
were performed according to the manufacturer’s descrip-
tion. The amount of urine analysed per strip was 30 μl
applied by pipette. Test results were visually interpreted,
including distinction of trace-signals (weak colouration
of the test line).
The UCP-LF CAA assay for urine was performed with
2 ml urine (the UCAA2000 assay format) as described
earlier [25]. In short, 2 ml urine was extracted with 2-ml
4% (w/v) trichloroactetic acid (TCA). An Amicon centri-
fugal filtration device was used to concentrate the result-
ing clear supernatant (approximately 4 ml) to a final
volume of 20–30 μl, of which 20 μl was analysed on
UCP-LF CAA test strips using the wet-reagents format
[25]. CAA concentrations were determined from stand-
ard series spiked in a negative urine sample and treated
similarly to the clinical urine samples. The quality
control (QC) cut-off threshold for singlet testing using
the UCAA2000 wet-assay is 0.1 pg CAA per ml urine
and the lower limit of detection = 0.05 pg/ml for testing
performed in triplicate. Samples generating test results
with a concentration between 0.05 and 0.1 pg per ml
were counted as indecisive; samples with test results
below 0.05 pg were considered CAA-negative [25].
The UCP-LF CAA assay for serum was performed
with 0.5 ml serum (SCAA500) as described earlier [25].
The procedure was the same as described above with
the difference that 0.5 ml TCA serum supernatant was
concentrated to a final volume of 20 μl and the QC cut-
off threshold was 1 pg CAA per ml serum with the
lower limit of detection = 0.5 pg/ml. Samples generating
test results with a concentration between 0.5 and 1 pg
per ml were counted as indecisive; samples with test re-
sults below 0.5 pg were considered CAA-negative [25].
Note that the ultrasensitive assay format, specifically
the SCAA500 test, is considered to allow identifica-
tion of the majority of all active infections (including
single-worm ones) [25]. In order to achieve the high-
est specificity, results were analysed considering the
POC-CCA trace scores as well as the urine- and
serum-CAA indecisive scores as negative. As this is a
preliminary analysis, we decided to follow a conserva-
tive approach [25]. Generally, samples generating test
results in the indecisive category would ideally require
retesting with a larger sample volume to verify the
true infection status.
Statistical analysis
Demographic details of participants and their exposure
to infection were obtained by questionnaire. Data were
digitally collected using electronic tablets. The question-
naires and forms were developed in Commcare (http://
www.commcarehq.org) format using the open data kit
(ODK) programme (version 2.8) that was installed on
the tablets for field data collection. Statistical analyses
were performed in STATA version 13.1 (Stata Corp.;
College Station, TX, USA). Only results from partici-
pants who had completed their questionnaires and stool
examination were included in the final analysis.
The intensity of infection, expressed as eggs per gram of
stool (EPG) obtained from Kato-Katz thick smear
examinations were classified as light, moderate or heavy
[33, 34]. The χ2-test was used to examine the association
of categorical variables. The Spearman rank correlation test
was used to correlate the results of the different diagnostic
tests with each other. Spearman r- and p-values were re-
ported. A p-value below 5% was considered statistically
significant.
The Schistosoma ELISA assay (a marker of former or
active infection) was composed of two separate assays,
one based on AWE and the other based on SEA. For
this study both these ELISAs were combined and an
overall interpretation of both test results was applied. A
result was interpreted as positive if at least one of the two
ELISA tests was positive. A result was interpreted as
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inconclusive if both ELISA tests generated an inconclusive
result. A result was considered negative if both ELISA
were negative.
Combined reference
We compared the diagnostic performance of all our
stool, urine- and serum-based diagnostic tests to a com-
bined reference. This consisted of a combination of test
results of the Kato-Katz test, the urine-CAA test and the
CAA-serum assay, all assays with a very high specificity,
in particular as we followed a conservative approach
accepting a relatively high cut-off threshold for the CAA
tests. The sensitivity, specificity, positive and negative
predictive values were calculated for all diagnostic tests
based on this composite measure. For these calcula-
tions, traces and indecisive tests results of CAA and
ELISA were taken as negative results. The urine- and
serum-CAA tests were also combined into a total
CAA outcome, which was deemed as positive when
at least one of the two tests produced a positive out-
come. This approach of comparing assays to a com-
bined reference is a widely recognized method for
assessment of diagnostic tests in the absence of a
highly sensitive and specific ‘gold’ standard method
and has been recommended by the WHO/TDR
Diagnostics Evaluation Expert Panel [35].
Results
Study population
Data records could be completed for a total of 377
persons and they were included in the analysis carried
out as shown schematically in Fig. 2. Of these, 196
(52.0%) were from Cambodia and 181 (48.0%) from Lao
PDR. The age of the participants ranged from 6 to
79 years with a median of 25 years; slightly more females
than males were enrolled (52.3% versus 47.8%). About
half of the participants had finished primary school
(53.3%); most of them were subsistence rice farmers
and fishermen (61.3%). The social and demographic
characteristics of study participants are summarised in
Table 1.
Egg detection
The status of the participants according to helminth infec-
tion intensity categories is shown in Table 2. Overall, S.
mekongi infection prevalence was 6.4% (24/377) with a
much higher prevalence of 12.7% (23 positives) in Lao
PDR, compared to 0.5% (one positive) in Cambodia. The
overall results for prevalence of other helminth infections,
such as O. viverrini, hookworm, Trichuris trichiura, Ascaris
lumbricoides and Taenia spp. were 50.4%, 28.1%, 3.5%,
0.3% and 1.9%, respectively. Significantly higher prevalence
rates were found for O. viverrini (90.1%), hookworm
(50.8%) and Taenia (3.3%) in Lao PDR. Multiparasitism
was observed in both countries with much higher fre-
quency in Lao PDR than in Cambodia. Table 3 shows infec-
tion intensity categories recorded as EPGs. All infections
were found to be light in Cambodia, while a large number
of the O. viverrini infections were of moderate intensity in
Lao PDR; some heavy infections (4 out of 181) were also
identified there.
Antigen detection
In total, 377 urine and serum samples were tested for
S. mekongi infection (Table 4). In the urine samples, the
CCA- and CAA-based test formats detected S. mekongi
infections in 21.0% and 38.7% of all subjects, respect-
ively. Compared to Cambodia, both urine tests diag-
nosed a higher S. mekongi prevalence in Lao PDR: 23.8%
versus 18.4% with respect to CCA, and 42.5% versus
35.2% with respect to CAA. In serum, the latter test
format detected a 32.4% overall prevalence with a similar
difference between the two countries as found with the
urine samples, 26.0% for Cambodia versus 39.2% for Lao
PDR.
Detection of S. mekongi antibodies
The combined results of the two ELISA tests were
positive in 34.5% of study participants, with a more
Fig. 2 Study diagram
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Table 1 Demographic characteristics of the study participants
Parameter Overall Cambodia Lao PDR χ2b P-valuec
n (%) n (%) n (%)
Number of subjects 377 (100) 196 (52.0) 181 (48.0)
Age (years)
Median (IQR)a 25 (12–44) 14 (11–35) 35 (15–47) NA NA
Sex
Male 180 (47.8) 101 (51.5) 79 (43.7)
Female 197 (52.3) 95 (48.5) 102 (56.4) 2.3 0.126
Age group (years)
≤ 9 40 (10.6) 25 (12.8) 15 (8.3)
10–16 116 (30.8) 82 (41.8) 34 (18.8)
17–36 92 (24.4) 43 (21.9) 49 (27.1)
37–50 68 (18.0) 22 (11.2) 46 (25.4)
≥ 51 61 (16.2) 24 (12.2) 37 (20.4) 33.5 <0.001
Educational level
Illiterate 11 (2.9) 0 11 (6.1)
Primary school 201 (53.3) 101 (51.5) 100 (55.3)
Secondary school 134 (35.5) 95 (48.5) 39 (21.6)
High school 23 (6.1) 0 23 (12.7)
Technical school or higher 8 (2.1) 0 8 (4.4) 64.9 <0.001
Occupation
Farmer/fisherman 231 (61.3) 101 (51.5) 130 (71.8)
Student 146 (38.7) 95 (48.5) 51 (28.2) 16.3 <0.001
(IQR)a Inter quantile range; bcomparison between countries; NA, not applicable,
Table 2 Prevalence of S. mekongi, O. viverrini and other helminth infections among all study participants according to Kato-Katz
examination
Helminth species Overall (%) Cambodia (%) Lao PDR (%) χ2a P- valuea
Number of subjects 377 (100) 196 (52.0) 181 (48.0)
Trematode
Schistosoma mekongi 24 (6.4) 1 (0.5) 23 (12.7) 23.5 <0.001
Opisthorchis viverrini 190 (50.4) 27 (13.8) 163 (90.1) 219.0 <0.001
Nematode
Hookworm 106 (28.1) 14 (7.1) 92 (50.8) 88.9 <0.001
Ascaris lumbricoides 1 (0.3) 0 1 (0.6) 1.1 0.297
Trichuris trichiura 13 (3.5) 7 (3.6) 6 (3.3) 0.02 0.892
Cestode
Taenia spp. 7 (1.9) 1 (0.5) 6 (3.3) 4.1 0.044
Multiparasitism
No infection 157 (41.6) 150 (76.5) 7 (3.9)
Single infection 115 (30.5) 42 (21.4) 73 (40.3)
Double infection 90 (23.9) 4 (2.0) 86 (47.5)
Triple infection 14 (3.7) 0 14 (7.7)
Quadruple infection 1 (0.3) 0 1 (0.6) 228.1 <0.001
aComparison between countries
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than 16% higher rate in Lao PDR than in Cambodia
(43.1% versus 26.5%). For all the diagnostic tests
performed, the positivity rates were statistically sig-
nificantly higher in Lao PDR compared to Cambodia
(Table 4).
Analysis of tests using the combined reference
We defined an active infection as an individual found
positive for CAA (in urine or serum) or with a positive
Kato-Katz thick smear. Table 5 shows the calculated
sensitivity and specificity and the predictive values of the
urine and serum tests in relation to this composite
measure. The combined CAA tests had the highest cal-
culated sensitivity (93.7%), followed by the urine-
(83.9%) and serum-CAA (70.1%) test. The combined
ELISA tests had a calculated sensitivity of 52.9% and a
specificity of 81.3% against this combined reference.
Triplicate Kato-Katz and single POC-CCA had a
comparatively low sensitivity of 13.8% and 24.1%, re-
spectively, and a negative predictive value of 57.5%
and 55.7%, respectively (Table 5).
Analysis with respect to age and sex
Table 6 shows the positivity rate of the different diagnostic
tests in relation to sex and age-groups. In general, all tests
showed a higher positivity rate in males. A peak of
positivity can be observed for the CAA tests in the age
group 10–16 years. The ELISA results did not decrease
with age to the same extent which could be explained by
persistence of antibody titres for long time even after
cured infections.
Table 3 Intensity of helminth infections among the infected
study participants according to Kato-Katz examination
Species/Type of infection Overall (%) Cambodia (%) Lao PDR (%)
Number of subjects 377 196 181
Schistosoma mekongi
Light infection 24 (100) 1 (100) 23 (100)
Opisthorchis viverrini
Light infection 116 (61.1) 27 (100) 89 (54.6)
Moderate infection 70 (36.8) 0 70 (42.9)
Heavy infection 4 (2.1) 0 4 (2.5)
Hookworm
Light infection 104 (98.1) 14 (100) 90 (97.8)
Moderate infection 2 (1.9) 0 2 (2.2)
Ascaris lumbricoides
Light infection 1 (100) 0 1 (100)
Trichuris trichiura
Light infection 12 (100) 6 (100) 6 (100)
Table 4 Diagnosis of S. mekongi infection using serum and urine samples (n = 377)
Type of sample/method Overall (%) Cambodia (%) Lao PDR (%) χ2 P-value
Urine
POC-CCA
Negative 174 (46.2) 97 (49.5) 77 (42.5)
Trace 124 (32.9) 63 (32.1) 61 (33.7)
Positive 79 (21.0) 36 (18.4) 43 (23.8) 2.4 0.308
UCAA
Negative 206 (54.6) 110 (56.1) 96 (53.0)
Indecisive range 25 (6.6) 17 (8.7) 8 (4.4)
Positive 146 (38.7) 69 (35.2) 77 (42.5) 4.0 0.133
Serum
SCAA
Negative 240 (63.7) 133 (67.9) 107 (59.1)
Indecisive range 15 (4.0) 12 (6.1) 3 (1.7)
Positive 122 (32.4) 51 (26.0) 71 (39.2) 10.9 0.004
ELISA combineda
Negative 115 (30.5) 76 (38.8) 39 (21.6)
Equivocal 132 (35.0) 68 (34.7) 64 (35.4)
Positive 130 (34.5) 52 (26.5) 78 (43.1) 16.7 <0.001
Combined Referenceb
Negative 203 (53.8) 121 (61.7) 82 (45.3)
Positive 174 (46.2) 75 (38.3) 99 (54.7) 10.2 0.001
AWE, adult worm antigen; SEA, soluble egg antigen; aeither AWE or SEA positive; bat least one of the three tests (UCAA, SCAA, Kato-Katz) positive
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Correlation analysis
Correlation analysis of the different diagnostic tests
showed positive and statistically significant correlations
between urine- and serum-CAA (r = 0.64, p < 0.001)
and combined ELISA tests with serum-CAA (r = 0.55,
p < 0.001) and urine-CAA (r = 0.38, p < 0.001). Further-
more, weakly positive but statistically significant cor-
relations were detected between the infection
intensity results of Kato-Katz and ELISA (r = 0.14,
p = 0.005), POC-CCA (r = 0.12, p = 0.017), and urine
(r = 0.11, 0.005) and serum-CAA (r = 0.17,
p = 0.001) (Fig. 3). The correlation of the POC-CCA
test results with the other tests were all weakly posi-
tive but statistically significant for urine-CAA
(r = 0.15, p = 0.003) and serum-CAA (r = 0.14,
p = 0.005). The correlation between the test results
of POC-CCA and ELISA were weakly positive but not
statistically significant (r = 0.09, p = 0.083).
Discussion
The implementation of preventive chemotherapy has
decreased schistosomiasis morbidity in endemic coun-
tries worldwide, including S. mekongi affected areas in
Cambodia and Lao PDR [36, 37]. The current lower
intensity of disease, however, is a compelling fact to rec-
ommend replacing stool examination using Kato-Katz
with more sensitive diagnostic tools. Serology based on
antibody detection is a helpful adjunct, but in order to
determine cure and the level of worm burdens
detection, assays based on the detection of circulating
antigens are required. This approach has been
successfully used for all major schistosome species
showing that it is 10–20 times more sensitive than
standard stool microscopy [17].
WHO recommends targeting schistosomiasis mekongi
for elimination as the endemic areas are very limited
and both stool examination according to Kato-Katz and
antibody testing using ELISA serology indicate low
intensity of disease after several rounds of preventive
chemotherapy [6]. However, as has already been shown
in the People’s Republic of China, highly sensitive tests
for schistosome circulating antigens give considerably
higher prevalence results than Kato-Katz [29]. With the
proof-of-principle of testing for excreted antigens in the
urine shown for S. mekongi [24], it was now felt that a field
study in the endemic areas in southern Lao PDR and
Table 5 Diagnostic characteristics of the various tests to diagnose S. mekongi infection using a combined referencea
Method ELISAb Kato-Katz POC-CCA CAA CAA CAA
Target Antibodies Parasite eggs Circulating antigens
Sample Serum Faeces Urine Urine Serum Serum + urine
(%) (%) (%) (%) (%) (%)
Sensitivity 52.9 13.8 24.1 83.9 70.1 93.7
Specificity 81.3 100 81.8 100 100 100
PPV* 70.8 100 53.2 100 100 100
NPV** 66.8 57.5 55.7 87.9 79.6 94.9
*Positive predictive value; **Negative predictive value; aInfection-positive by either egg- or CAA-positivity (serum and urine combined, assuming 100% specificity
of the CAA result). bFor the ELISA, either AWE and/or SEA positive was considered positive
Table 6 Sex and age distribution of S. mekongi infection: results of various approaches
Method ELISA Kato-Katz POC-CCA CAA CAA CAA
Target Antibodies Parasite eggs Circulating antigens
Sample Serum Faeces Urine Urine Serum Serum + urine
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Sex
Male 68 (37.8) 15 (8.3) 39 (21.7) 71 (39.4) 65 (36.1) 80 (44.4)
Female 62 (31.5) 9 (4.6) 40 (20.3) 75 (38.1) 57 (28.9) 83 (42.1)
Age group (years)
≤ 9 3 (7.5) 1 (2.5) 6 (15.0) 8 (20.0) 6 (15.0) 9 (22.5)
10–16 44 (37.9) 2 (1.7) 25 (21.6) 56 (48.3) 53 (45.7) 64 (55.2)
17–36 36 (39.1) 10 (10.9) 23 (25.0) 39 (42.4) 27 (29.4) 42 (45.7)
37–50 25 (36.8) 6 (8.8) 9 (13.2) 22 (32.4) 19 (27.9) 24 (35.3)
≥ 51 22 (36.1) 5 (8.2) 16 (26.2) 21 (34.4) 17 (27.9) 24 (39.3)
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northern Cambodia would be warranted to establish this
approach. In contrast to antibody detection, the Kato-Katz
stool examinations along with the tests for circulating
schistosome antigens (POC-CCA and UCP-LF-CAA) are
all indicators of active infections. Antibody titres can per-
sist for very long time after cure and therefore serology is
not suitable for assessing treatment outcomes or as single
diagnostic approach for detection of active infections.
In the field, detection of active infection and cure are all
highly important, particularly when moving from control
of a disease to transmission interruption and elimination.
It is equally important for the individual patient. While
the better sensitivity of antigen detection compared to
Kato-Katz is obvious, it is also clear that CAA detection
(both in serum and urine) performs much better than
CCA. These results are in agreement with previous
reports for S. japonicum and S. mekongi [24, 29, 38].
The advantage of the POC-CCA test is that it is a
standardized urine test applicable in the field without
the need for any extra equipment (fulfilling all ‘AS-
SURED’ characteristics). It has been mainly and widely
validated for S. mansoni detection, but shows limited
use for the other schistosome species [23]. However
specificity is limited to some extent, because CCA has
epitopes common with certain human components
(Lewis-X structures) that sometimes end up in the urine
causing false positive reactions [39]. The UCP-LF CAA
test, on the other hand, is applicable for all schistosome
species and for various human liquid samples, such as
urine and serum, as well as potentially saliva [25]. In
contrast to the POC-CCA assay, the UCP-LF CAA test
format is not yet commercially available nor is its
current format applicable for POC application because
of a sample preparation procedure and the use of an
UCP strip-reader. While the cost of the former is US$
1–1.5 per test, that of the latter, being a manual labora-
tory test, is at least 10-fold higher. However, as shown
here, the UCP-LF CAA test does display a superior
sensitivity by concentration of the clinical sample and
may therefore detect single-worm infections [25]. Still, as
our results show that the POC-CCA assay is applicable
for field diagnosis of S. mekongi, this assay should be the
approach of choice for schistosomiasis diagnosis in Lao
PDR and Cambodia with the current infrastructure.
Fig. 3 Correlation between combined ELISA (top left), POC-CCA (bottom left) and urine (top right) and serum CAA (bottom right) and infection
intensity of Schistosoma mekongi (eggs per gram of stool)
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We found a strong correlation of the test results of the
urine and serum CAA tests and ELISA, while the correla-
tions between the two CAA tests and the Kato-Katz and
POC-CCA were weaker. These observations are consist-
ent with previous studies in the People’s Republic of China
[29] and elsewhere [28, 40] and are largely a reflection of
the different sensitivities of these diagnostic tests.
It should be mentioned that the results presented here
are interpreted rather conservatively with respect to the
cut-off threshold, leaving the POC-CCA trace scores and
the UCP-LF CAA indecisive values as negatives. A more
detailed comparison of the different assays using e.g.,
latent class analysis may shed a better insight in the actual
status of trace and indecisive samples. Such additional
analyses, incorporating also a quantitative analysis of the
POC-CCA results using a gold strip reader, are being
planned.
In agreement with previous evaluations of the various
assays for circulating schistosome antigens in areas
endemic for other schistosome species, we found that
the POC-CCA is both more rapid and more sensitive
than multiple Kato-Katz thick smears. In the present
study, the number of positives identified by POC-CCA
was significantly higher than those found by Kato-Katz
in both counties. These results are in accordance with
published results which showed that POC-CCA preva-
lence was between 1.5- and up to 6-fold higher than
Kato-Katz prevalence estimates in areas with low infec-
tion intensity [23]. The comparable cost levels per deter-
mination for POC-CCA and Kato-Katz [41, 42] should
not prevent the application of the rapid test in national
schistosomiasis control programmes. Furthermore,
people are more likely to provide urine samples than any
other type of sample, leading to higher compliance.
While eggs continue to be excreted by the host for a
few weeks after cure, both CCA- and CAA-levels drop
quickly, sometimes turning negative within 1 week after
treatment [40, 43], making this approach a promising
tool to monitor drug efficacy. The sensitivity of CCA-
based tests is not as high as what the UCP-LF CAA
assay or what DNA-based detection methods can offer
[44, 45], while the ultrasensitive SCAA500 format of the
UCP-LF CAA test surpasses PCR in sensitivity [46, 47].
As many different diagnostic assay systems are now
available, planning to assess geographic areas potentially
endemic for schistosomiasis, multiple diagnostic ap-
proaches should be compared taking into account
modelling and statistical methods in combination with
knowledge how biological systems operate [28, 48].
Conclusion
Where low egg counts are most common, such as in
areas characterised by low endemicity slated for elimin-
ation, the sensitivity and specificity of diagnostic tests
must be taken into account when deciding which
approach to choose. CCA-based assays are already
available for use in the field, but tests targeting CAA still
need the laboratory due to some of the sample prepar-
ation steps. Although the latter approach is the most
sensitive antigen test, it would still be useful to apply
POC-CCA testing for screening. While the results pre-
sented here will be subjected to further analysis, it would
be useful to start planning for wider testing including
application of geographical information systems to
establish the real boundaries of the areas endemic for
S. mekongi, prevalence and intensity of disease before
moving on to transmission control and eventual elimin-
ation of the disease in Cambodia and Lao PDR.
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